OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) EBIT Margin (2024 - 2026)

OSR Health (OSRHW) posted EBIT Margin of 757.59% for Q1 2026, up 54.77% sequentially from 1674.81% in Q4 2025, and down 37431.0% YoY from N/an in Q1 2025.

OSR Health (OSRHW) EBIT Margin (2024 - 2026) Analysis & Trends

OSR Health has reported EBIT Margin for 3 years, with the latest figure at 757.59% in Q1 2026.

  • Quarterly EBIT Margin fell 37431.0% year-over-year to 757.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 726.07% (down 39173.0% YoY) and the FY2025 annual result came in at 631.01%, down 29988.0% from the prior year.
  • EBIT Margin rose to 757.59% in Q1 2026 per OSRHW's latest filing, from 1674.81% in the prior quarter.
  • Over five years, EBIT Margin peaked at 176.0% in Q4 2024 and troughed at 1674.81% in Q4 2025.
  • A 3-year average of 579.81% and a median of 433.36% in 2024 frame the typical range for EBIT Margin.
  • The widest YoY moves for EBIT Margin: up 2046 bps in 2025, down 149881 bps in 2025.
  • Over 3 years, EBIT Margin stood at 176.0% in 2024, then slumped by 852 bps to 1674.81% in 2025, then jumped by 55 bps to 757.59% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods registered 757.59%, 1674.81%, and 605.89% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 30.15%
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn 32.54%
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn -562.07%
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn 17.93%
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn -35.57%
8 Royalty Pharma 27.29 Bn 26.45 Bn - 19.75%
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn -0.36%
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 -960.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 -757.59%
Dec 31, 2025 -1,674.81%
Sep 30, 2025 -605.89%
Jun 30, 2025 -460.51%
Mar 31, 2025 -383.28%
Dec 31, 2024 -176.00%
Sep 30, 2024 -433.36%
Jun 30, 2024 -364.03%
Mar 31, 2024 -362.83%